SC
DRTX

Sophrosyne Capital’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Sophrosyne Capital’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-105,500
Closed -$1.42M – 91
2014
Q1 		$1.42M Buy
+105,500
New +$1.38M 1.25% 25

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sophrosyne Capital's DRTX Position: Q2 2014 in Review

Sophrosyne Capital sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q2 2014, closing a stake of 105,500 shares — an estimated $1.42M sold.

Sophrosyne Capital first reported a position in DRTX in Q1 2014 and held it in 1 quarter. The position peaked at $1.42M in Q1 2014. 74 funds tracked by Wall St. Rank hold DRTX as of Q2 2014.

  • Sophrosyne Capital reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 105,500 DURATA THERAPEUTICS INC COM STK (DE) shares in Q2 2014, an estimated $1.42M.
  • Sophrosyne Capital first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Sophrosyne Capital's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.42M in Q1 2014.
  • 74 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q2 2014.

Based on Sophrosyne Capital's 13F filing for Q2 2014, filed 14 Aug 2014.